Evidence map›Paper›PMID 30111930›Full record

ArticleIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine2018

Bijayini Behera, Srujana Mohanty, Subhrajyoti Sahu, Ashok Kumar Praharaj

Abstract read
In one paragraph

Article in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Observational
  2. Article
  3. IJID regions · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Enzyme Patterns and Factors Associated with Mortality among Patients with Carbapenem ResistantIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2023
    Article
  9. Article
  10. Article
  11. Fosfomycin Resistance Evolutionary Pathways ofInternational journal of molecular sciences · 2022
    Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bijayini BeheraDepartment of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Srujana MohantyDepartment of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Subhrajyoti SahuDepartment of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Ashok Kumar PraharajDepartment of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe era of multidrug-resistant (MDR) Gram-negative bacilli (GNB) has renewed interest in fosfomycin.

aimThe present study evaluated the MATERIALS AND

methodsFosfomycin susceptibility was carried out by agar dilution for a total of 279 (142 from urine and 137 from other samples) MDR-GNB. Disk diffusion was done for urinary isolates only.

resultsUrinary tract isolates had a high degree of susceptibility to fosfomycin (overall susceptibility, 90.8%), whereas only 42.9% of nonurinary isolates retained susceptibility to the drug. Percentage susceptibility rates for urinary and nonurinary isolates of

conclusionFosfomycin showed excellent

Indexed as

Fosfomycinmultidrug-resistant Gram-negative bacilliurinary tract infection

Identifiers

PMID30111930
PMCPMC6069321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.